Assessing Functional Similarity of Biosimilar ABP 654 and Ustekinumab in Samples from Patients with Crohn’s Disease
Ian N Foltz,1 Kevin Gaida,2 Helen Y Wong,1 Michael Ng,1 Marijana Busch,1 Jennifer L Liu3 1Amgen Research, Department of Therapeutic Discovery, Amgen Inc., Burnaby, BC, V5A1V7, Canada; 2Research and Development, Amgen Inc., Thousand Oaks, CA, 91320, USA; 3Biosimilar Process Development, Amgen Inc., T...
Saved in:
| Main Authors: | Foltz IN, Gaida K, Wong HY, Ng M, Busch M, Liu JL |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2024-12-01
|
| Series: | Journal of Inflammation Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/assessing-functional-similarity-of-biosimilar-abp-654-and-ustekinumab--peer-reviewed-fulltext-article-JIR |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Osteonecrosis of the jaw associated with ustekinumab in the treatment of Crohn's disease
by: Jean Massaad, et al.
Published: (2024-10-01) -
Nonclinical Similarity of the Biosimilar Candidate ABP 938 with Aflibercept Reference Product
by: Neungseon Seo, et al.
Published: (2024-11-01) -
Evaluation of rheumatologists’ knowledge of biosimilars
by: Thayane Furtado Rolim Lima, et al.
Published: (2025-07-01) -
Ustekinumab Biosimilars
by: Elena Carmona-Rocha, et al.
Published: (2024-11-01) -
Effect of Risankizumab Induction and Maintenance Therapy on the Rate of Hospitalization in Patients with Crohn’s Disease
by: Brian G. Feagan, et al.
Published: (2025-01-01)